PDEX

+ Watchlist + Portfolio

Pro-Dex, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $66.94
52-Week Range: $23.47 – $69.86
Market Cap: $211.71M
P/E (TTM): 18.27
EPS (TTM): 3.63
Dividend Yield: —

Advanced Metrics

Price/Book: 4.69
PEG Ratio: —
Return on Equity: 29.83%
Return on Assets: 9.70%
Gross Margin: 27.78%
Operating Margin: 15.51%
Profit Margin: 16.08%
Current Ratio: 3.67
Debt/Equity: 0.45
Total Debt: $20.17M
Free Cash Flow: $5.40M
Revenue Growth: 14.60%
Earnings Growth: 22.40%
Enterprise Value: $222.92M

PDEX Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$42.04M	$46.09M	$53.84M	$66.59M
Cost of Revenue	$28.91M	$33.34M	$39.29M	$47.08M
Gross Profit	$13.13M	$12.75M	$14.55M	$19.51M
Research & Development	$2.98M	$2.80M	$3.19M	$3.64M
Selling, General & Admin	$4.99M	$4.18M	$4.19M	$5.18M
Operating Expenses	$7.97M	$6.99M	$7.38M	$8.82M
Operating Income	$5.16M	$5.76M	$7.17M	$10.69M
EBITDA	$6.88M	$10.82M	$4.35M	$14.13M
Pretax Income	$5.69M	$9.43M	$2.63M	$12.06M
Income Tax	$1.12M	$2.35M	$507.00K	$3.08M
Net Income	$4.57M	$7.07M	$2.13M	$8.98M
Diluted EPS	1.02	1.98	0.60	2.67
Diluted Shares	3.76M	3.64M	3.57M	3.36M

PDEX Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$849.00K	$2.94M	$2.63M	$419.00K
Receivables	$15.38M	$9.95M	$13.89M	$17.49M
Inventory	$12.68M	$16.17M	$15.27M	$22.21M
Current Assets	$31.17M	$30.98M	$36.61M	$47.30M
Total Assets	$49.09M	$51.82M	$52.48M	$61.19M
Current Liabilities	$11.35M	$9.68M	$12.89M	$14.63M
Long-Term Debt	$10.25M	$8.91M	$7.54M	$9.25M
Total Debt	$15.97M	$14.79M	$13.55M	$16.58M
Total Liabilities	$23.66M	$20.23M	$21.61M	$24.56M
Retained Earnings	$17.75M	$24.82M	$26.95M	$35.93M
Shareholders' Equity	$25.43M	$31.59M	$30.87M	$36.63M
Working Capital	$19.81M	$21.30M	$23.72M	$32.67M
Net Debt	$12.69M	$9.80M	$9.28M	$14.97M

PDEX Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$847.00K	$5.46M	$6.22M	-$1.68M
Capital Expenditure	-$1.67M	-$974.00K	-$983.00K	-$1.25M
Free Cash Flow	-$2.52M	$4.49M	$5.24M	-$2.93M
Depreciation & Amortisation	$726.00K	$857.00K	$1.16M	$1.24M
Stock-Based Compensation	$1.27M	$766.00K	$605.00K	$555.00K
Investing Cash Flow	-$1.24M	-$885.00K	-$2.23M	-$238.00K
Financing Cash Flow	-$790.00K	-$2.49M	-$4.30M	-$292.00K
Share Repurchases	-$1.61M	-$1.55M	-$3.50M	-$3.50M
Net Change in Cash	-$2.87M	$2.09M	-$305.00K	-$2.21M

PDEX Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$17.41M	$17.49M	$18.53M	$18.66M	$19.95M
Cost of Revenue	$11.62M	$14.00M	$13.16M	$12.92M	$13.82M
Gross Profit	$5.80M	$3.49M	$5.37M	$5.74M	$6.13M
Research & Development	$947.00K	$905.00K	$768.00K	$734.00K	$827.00K
Selling, General & Admin	$1.21M	$1.24M	$1.49M	$1.75M	$2.21M
Operating Expenses	$2.16M	$2.15M	$2.26M	$2.48M	$3.04M
Operating Income	$3.64M	$1.34M	$3.11M	$3.26M	$3.09M
EBITDA	$5.11M	$2.14M	$6.73M	$3.38M	$5.90M
Pretax Income	$4.55M	$1.60M	$6.22M	$2.93M	$5.34M
Income Tax	$1.28M	$402.00K	$1.54M	$741.00K	$1.40M
Net Income	$3.27M	$1.20M	$4.68M	$2.19M	$3.94M
Diluted EPS	0.98	0.36	1.40	0.66	1.20
Diluted Shares	3.34M	3.35M	3.34M	3.30M	3.27M

PDEX Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$4.47M	$419.00K	$514.00K	$7.95M	$9.99M
Receivables	$15.86M	$17.49M	$18.34M	$18.15M	$19.77M
Inventory	$23.43M	$22.21M	$21.56M	$21.71M	$22.36M
Current Assets	$49.94M	$47.30M	$50.72M	$49.19M	$53.71M
Total Assets	$64.27M	$61.19M	$64.30M	$62.26M	$74.98M
Current Liabilities	$18.32M	$14.63M	$13.60M	$12.20M	$14.64M
Long-Term Debt	$9.86M	$9.25M	$8.63M	$8.01M	$14.30M
Total Debt	$19.10M	$16.58M	$13.79M	$10.89M	$19.33M
Total Liabilities	$28.99M	$24.56M	$22.79M	$20.63M	$29.78M
Retained Earnings	$34.73M	$35.93M	$40.61M	$41.63M	$45.20M
Shareholders' Equity	$35.28M	$36.63M	$41.51M	$41.63M	$45.20M
Working Capital	$31.63M	$32.67M	$37.12M	$36.98M	$39.07M
Net Debt	$13.82M	$14.97M	$12.73M	$2.52M	$8.50M

PDEX Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$754.00K	-$173.00K	$2.31M	$3.57M	$1.63M
Capital Expenditure	-$180.00K	-$93.00K	—	—	-$112.00K
Free Cash Flow	$574.00K	-$266.00K	$2.31M	$3.40M	$1.52M
Depreciation & Amortisation	$310.00K	$314.00K	$311.00K	$314.00K	$363.00K
Stock-Based Compensation	$158.00K	$154.00K	$161.00K	$164.00K	$186.00K
Investing Cash Flow	$1.73M	-$992.00K	-$98.00K	$8.87M	-$5.05M
Financing Cash Flow	$1.93M	-$2.89M	-$2.12M	-$5.00M	$5.46M
Share Repurchases	$0.00	$0.00	$0.00	-$2.21M	-$601.00K
Net Change in Cash	$4.41M	-$4.05M	$95.00K	$7.44M	$2.04M

Market Snapshot

About

Pro-Dex designs, develops, and manufactures powered surgical instruments and rotary drive systems for the medical device and dental industries. Products include handpieces, motors, and accessories used in orthopedic, oral, and maxillofacial surgical procedures. The company also serves industrial markets with precision rotary tools.